In fact, the correlation of high ENOX2 mRNA expression with poorer survival that we discovered for melanoma is supported by data from Lin et al. [59], who found a similar effect for hepatocellular carcinoma and breast cancer. This evidence concerns the gene ENOX2 and hepatocellular carcinoma.